About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ALGS
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Aligos Therapeutics files to sell 168.73M shares of common stock
- Aligos Therapeutics GAAP EPS of -$0.41
- Aligos Therapeutics director buys shares worth $6M
- Aligos Therapeutics stock plummets on $92M private placement financing
- Aligos Therapeutics GAAP EPS of -$0.43 beats by $0.06, revenue of $2.59M
- Aligos Therapeutics and Xiamen Amoytop Biotech join hands for the treatment of liver diseases
- Aligos Therapeutics GAAP EPS of -$0.53 misses by $0.05, revenue of $2.58M
- Aligos Therapeutics GAAP EPS of -$0.51 misses by $0.02, revenue of $3.54M beats by $1.39M
- Aligos Therapeutics in portfolio reorganization focused on NASH, COVID assets
- Aligos Therapeutics GAAP EPS of -$0.44 beats by $0.14, revenue of $4.12M beats by $3.37M
- Aligos Therapeutics files court response and counterclaims to J&J's allegations of theft
- Aligos Therapeutics GAAP EPS of -$0.47 beats by $0.18, revenue of $3.69M
- Aligos Therapeutics begins 12-week dosing in phase 1b study to treat hepatitis B
- Aligos Therapeutics GAAP EPS of -$0.84, revenue of $2.57M
- Aligos to advance development of oral drug candidate ALG-097558 for COVID-19
- Aligos halts development of Hep B candidate on safety concerns
- Aligos Therapeutics GAAP EPS of -$0.89 misses by $0.06
- Aligos Therapeutics begins dosing in phase 1 trial of ALG-020572 in hepatitis B patients
- Aligos expands collaboration with Merck to develop oligonucleotide therapies for NASH
- Aligos falls on decision to halt development of chronic hepatitis B candidate
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
Aug 7, 2023 | 0.89 | 0.91 |
0.97
|
0.88
|
444K | 1.14% | ||||
Aug 4, 2023 | 0.88 | 0.94 |
0.94
|
0.87
|
26.0K | -1.12% | ||||
Aug 3, 2023 | 0.89 | 0.91 |
0.94
|
0.88
|
51.1K | -1.11% | ||||
Aug 2, 2023 | 0.9 | 0.89 |
0.9
|
0.86
|
84.2K | 2.27% | ||||
Aug 1, 2023 | 0.88 | 0.9 |
0.92
|
0.87
|
80.9K | -1.12% | ||||
Jul 31, 2023 | 0.89 | 0.9 |
0.92
|
0.86
|
140K | 1.14% | ||||
Jul 28, 2023 | 0.88 | 0.88 |
0.92
|
0.87
|
66.1K | 0% | ||||
Jul 27, 2023 | 0.88 | 0.9 |
0.92
|
0.87
|
66.9K | -2.22% | ||||
Jul 26, 2023 | 0.9 | 0.92 |
0.94
|
0.88
|
230K | -3.23% | ||||
Jul 25, 2023 | 0.93 | 0.92 |
0.99
|
0.92
|
25.8K | 1.09% | ||||
Jul 24, 2023 | 0.92 | 0.96 |
0.96
|
0.91
|
40.7K | -3.16% | ||||
Jul 21, 2023 | 0.95 | 0.96 |
1.05
|
0.95
|
62.7K | -5% | ||||
Jul 20, 2023 | 1 | 1.01 |
1.02
|
1
|
22.0K | 0% | ||||
Jul 19, 2023 | 1 | 1.07 |
1.07
|
1
|
46.3K | -3.85% | ||||
Jul 18, 2023 | 1.04 | 1.05 |
1.06
|
1
|
39.6K | -1.89% | ||||
Jul 17, 2023 | 1.06 | 1.06 |
1.1
|
1.03
|
169K | 2.91% | ||||
Jul 14, 2023 | 1.03 | 0.98 |
1.08
|
0.93
|
373K | 7.29% | ||||
Jul 13, 2023 | 0.96 | 0.91 |
0.98
|
0.91
|
130K | 3.23% | ||||
Jul 12, 2023 | 0.93 | 0.92 |
0.97
|
0.91
|
23.5K | 3.33% | ||||
Jul 11, 2023 | 0.9 | 0.93 |
0.96
|
0.89
|
228K | -3.23% | ||||
Jul 10, 2023 | 0.93 | 0.98 |
0.99
|
0.93
|
75.1K | -4.12% | ||||
Jul 7, 2023 | 0.97 | 1.06 |
1.06
|
0.96
|
20.8K | -2.02% | ||||
Jul 6, 2023 | 0.99 | 1 |
1.02
|
0.94
|
9.6K | 1.02% | ||||
Jul 5, 2023 | 0.98 | 0.98 |
1.03
|
0.97
|
69.1K | -2% | ||||
Jul 3, 2023 | 1 | 0.97 |
1.03
|
0.97
|
84.1K | 3.09% | ||||
Jun 30, 2023 | 0.97 | 0.92 |
0.99
|
0.92
|
90.8K | 4.30% | ||||
Jun 29, 2023 | 0.93 | 0.97 |
0.98
|
0.91
|
49.7K | 0% | ||||
Jun 28, 2023 | 0.93 | 0.91 |
1.05
|
0.87
|
370K | 2.20% | ||||
Jun 27, 2023 | 0.91 | 0.95 |
0.96
|
0.91
|
114K | -3.19% | ||||
Jun 26, 2023 | 0.94 | 0.98 |
1.02
|
0.93
|
59.1K | -3.09% | ||||
Jun 23, 2023 | 0.97 | 0.97 |
0.99
|
0.95
|
91.8K | 0% | ||||
Jun 22, 2023 | 0.97 | 1 |
1.05
|
0.92
|
111K | -3.96% | ||||
Jun 21, 2023 | 1.01 | 1.08 |
1.08
|
1
|
72.5K | -2.88% | ||||
Jun 20, 2023 | 1.04 | 1.1 |
1.12
|
1.04
|
43.0K | -5.45% | ||||
Jun 16, 2023 | 1.1 | 1.1 |
1.11
|
0.95
|
1.3M | 0% | ||||
Jun 15, 2023 | 1.1 | 1.12 |
1.16
|
1.08
|
185K | 0% | ||||
Jun 14, 2023 | 1.1 | 1.1 |
1.14
|
1.09
|
42.4K | -1.79% | ||||
Jun 13, 2023 | 1.12 | 1.15 |
1.17
|
1.09
|
44.5K | -0.88% | ||||
Jun 12, 2023 | 1.13 | 1.12 |
1.18
|
1.09
|
25.2K | 0.89% | ||||
Jun 9, 2023 | 1.12 | 1.12 |
1.16
|
1.08
|
35.3K | 1.82% | ||||
Jun 8, 2023 | 1.1 | 1.19 |
1.19
|
1.1
|
87.9K | -2.65% | ||||
Jun 7, 2023 | 1.13 | 1.16 |
1.21
|
1.08
|
149K | -4.24% | ||||
Jun 6, 2023 | 1.18 | 1.12 |
1.19
|
1.1
|
32.7K | 3.51% | ||||
Jun 5, 2023 | 1.14 | 1.2 |
1.2
|
1.14
|
31.0K | -4.2% | ||||
Jun 2, 2023 | 1.19 | 1.19 |
1.21
|
1.12
|
125K | 0% | ||||
Jun 1, 2023 | 1.19 | 1.15 |
1.22
|
1.1
|
156K | 5.31% | ||||
May 31, 2023 | 1.13 | 1.1 |
1.16
|
1.07
|
30.9K | -0.88% | ||||
May 30, 2023 | 1.14 | 1.11 |
1.14
|
1.09
|
44.8K | 1.79% | ||||
May 26, 2023 | 1.12 | 1.11 |
1.12
|
1.09
|
32.6K | 1.82% | ||||
May 25, 2023 | 1.1 | 1.11 |
1.12
|
1.08
|
71.3K | -0.9% | ||||
May 24, 2023 | 1.11 | 1.07 |
1.12
|
1.05
|
61.2K | 3.74% | ||||
May 23, 2023 | 1.07 | 1.06 |
1.18
|
1.06
|
208K | 0.94% | ||||
May 22, 2023 | 1.06 | 1.13 |
1.17
|
1.02
|
258K | 2.91% | ||||
May 19, 2023 | 1.03 | 1.1 |
1.13
|
1.03
|
188K | -7.21% | ||||
May 18, 2023 | 1.11 | 1.16 |
1.2
|
1.1
|
149K | -6.72% | ||||
May 17, 2023 | 1.19 | 1.1 |
1.25
|
1.1
|
261K | 3.48% | ||||
May 16, 2023 | 1.15 | 1.22 |
1.27
|
1.1
|
501K | -11.54% | ||||
May 15, 2023 | 1.3 | 1.3 |
1.34
|
1.15
|
5.5M | 19.27% | ||||
May 12, 2023 | 1.09 | 1.09 |
1.14
|
1.03
|
863K | -2.68% | ||||
May 11, 2023 | 1.12 | 1.25 |
1.25
|
1.12
|
32.9K | 0% |